Position in CRDL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,727
-$26,060 QoQ
Shares Held
42,196
-19.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 52 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,170,492 across 66 Drug Manufacturers - Specialty & Generic names. CRDL ranks #58 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in CRDL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,727 | 42,196 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $70,787 | 52,435 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,022 | 52,435 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $56,105 | 52,435 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $71,311 | 52,435 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $50,861 | 52,435 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $67,116 | 52,435 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $103,821 | 52,435 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $105,918 | 52,435 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $94,907 | 52,435 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $44,202 | 52,435 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $46,929 | 52,435 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $46,667 | 52,435 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,535 | 52,435 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,741 | 52,435 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $54,008 | 52,435 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $69,214 | 52,435 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $80,225 | 52,435 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $97,004 | 52,435 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $217,605 | 52,435 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||